Summit Therapeutics (SUMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 187.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 242.50
  • 52 Week Low: 142.50
  • Currency: UK Pounds
  • Shares Issued: 73.56m
  • Volume: 121
  • Market Cap: 137.93m
  • RiskGrade: 205

SUMM Overview

Summit Therapeutics is in the pharma and biotech sector and is currently trading at 187.50p per share. In the last year Summit Therapeutics 's share price has ranged from 142.50p to 242.50p.

1 Day Chart (16-01-2018)

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1080.4% n/a
ROCE 2360.9%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 60.0 n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SUMM Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-13 1.81 (4.57) (26.80)p n/a n/a n/a n/a 0.0%
31-Jan-14 1.38 (6.70) (30.00)p n/a n/a n/a n/a 0.0%
31-Jan-15 1.17 (12.66) (29.00)p n/a n/a n/a n/a 0.0%
31-Jan-16 n/a (23.20) (34.00)p n/a n/a n/a n/a 0.0%
31-Jan-17 2.30 (25.71) (35.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SUMM Company Announcements

Summit Therapeutics to Present at the Biotech Sh... 09-Jan-2018 12:00 GlobeNewswire EU
Acquisition of Discuva Ltd 27-Dec-2017 07:00 RNS
Summit Enters Licence and Commercialisation Agre... 21-Dec-2017 07:00 GlobeNewswire EU

Latest SUMM Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

SUMM Market Data

Currency UK Pounds
Share Price 187.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 242.50
52 Week Low 142.50
Volume 121
Shares Issued 73.56m
Market Cap 137.93m
RiskGrade 205

SUMM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
4.80% above the market average4.80% above the market average4.80% above the market average4.80% above the market average4.80% above the market average
27.87% below the sector average27.87% below the sector average27.87% below the sector average27.87% below the sector average27.87% below the sector average
Price Trend
37.46% above the market average37.46% above the market average37.46% above the market average37.46% above the market average37.46% above the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average
Income Not Available
Growth Not Available

SUMM Dividends

No dividends found

Trades for 16-Jan-2018

Time Volume / Share Price
15:12 50 @ 185.10p
09:36 71 @ 185.10p

SUMM Key Personnel

CEO Glyn Edwards
COO David Roblin

Top of Page